BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Powell EE, Ali A, Clouston AD, Dixon JL, Lincoln DJ, Purdie DM, Fletcher LM, Powell LW, Jonsson JR. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology. 2005;129:1937-1943. [PMID: 16344062 DOI: 10.1053/j.gastro.2005.09.015] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Falize L, Guillygomarc'h A, Perrin M, Lainé F, Guyader D, Brissot P, Turlin B, Deugnier Y. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology. 2006;44:472-477. [PMID: 16871557 DOI: 10.1002/hep.21260] [Cited by in Crossref: 149] [Cited by in F6Publishing: 115] [Article Influence: 9.3] [Reference Citation Analysis]
2 Dyson JK, McPherson S, Anstee QM. Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. Postgrad Med J. 2014;90:254-266. [PMID: 24737902 DOI: 10.1136/postgradmedj-2013-201620rep] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
3 Pietrangelo A. Hemochromatosis: An endocrine liver disease. Hepatology 2007;46:1291-301. [DOI: 10.1002/hep.21886] [Cited by in Crossref: 155] [Cited by in F6Publishing: 117] [Article Influence: 10.3] [Reference Citation Analysis]
4 Deugnier Y, Lainé F, Le Lan C, Bardou-jacquet E, Jouanolle A, Brissot P. Hémochromatoses et autres surcharges hépatiques en fer. EMC - Hépatologie 2011;6:1-12. [DOI: 10.1016/s1155-1976(11)40364-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Olynyk JK, Trinder D, Ramm GA, Britton RS, Bacon BR. Hereditary hemochromatosis in the post-HFE era. Hepatology. 2008;48:991-1001. [PMID: 18752323 DOI: 10.1002/hep.22507] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
6 Cowin GJ, Jonsson JR, Bauer JD, Ash S, Ali A, Osland EJ, Purdie DM, Clouston AD, Powell EE, Galloway GJ. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28:937-945. [PMID: 18821619 DOI: 10.1002/jmri.21542] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 10.6] [Reference Citation Analysis]
7 Barton JC, McLaren CE, Chen WP, Ramm GA, Anderson GJ, Powell LW, Subramaniam VN, Adams PC, Phatak PD, Gurrin LC, Phillips JD, Parker CJ, Emond MJ, McLaren GD. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. Ann Hepatol 2018;17:871-9. [PMID: 30145563 DOI: 10.5604/01.3001.0012.3169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
8 Rombout-Sestrienkova E, van Kraaij MG, Koek GH. How we manage patients with hereditary haemochromatosis. Br J Haematol 2016;175:759-70. [PMID: 27723100 DOI: 10.1111/bjh.14376] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
9 Carneiro MV, Souza FF, Teixeira AC, Figueiredo JF, Villanova MG, Secaf M, Passos AD, Ramalho LN, Carneiro FP, Zucoloto S. The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2010;22:1204-1210. [PMID: 20555268 DOI: 10.1097/meg.0b013e32833bec1e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Folgueras AR, Freitas-Rodríguez S, Ramsay AJ, Garabaya C, Rodríguez F, Velasco G, López-Otín C. Matriptase-2 deficiency protects from obesity by modulating iron homeostasis. Nat Commun 2018;9:1350. [PMID: 29636509 DOI: 10.1038/s41467-018-03853-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
11 Philippe MA, Ruddell RG, Ramm GA. Role of iron in hepatic fibrosis: One piece in the puzzle. World J Gastroenterol 2007; 13(35): 4746-4754 [PMID: 17729396 DOI: 10.3748/wjg.v13.i35.4746] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
12 Hoda K, Bowlus CL, Chu TW, Gruen JR. Iron Metabolism and Related Disorders. Emery and Rimoin's Principles and Practice of Medical Genetics. Elsevier; 2013. pp. 1-41. [DOI: 10.1016/b978-0-12-383834-6.00106-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Wood MJ, Powell LW, Ramm GA. Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood. 2008;111:4456-4462. [PMID: 18316631 DOI: 10.1182/blood-2007-11-122374] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
14 Deugnier Y, Mosser J. Modifying factors of the HFE hemochromatosis phenotype. Expert Rev Gastroenterol Hepatol 2008;2:531-40. [PMID: 19072401 DOI: 10.1586/17474124.2.4.531] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
15 Pietrangelo A. Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin. Gastroenterology 2015;149:1240-1251.e4. [DOI: 10.1053/j.gastro.2015.06.045] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
16 Tiniakos DG, Anstee QM, Burt AD. Fatty Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 308-71. [DOI: 10.1016/b978-0-7020-6697-9.00005-4] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. World J Gastroenterol 2012; 18(22): 2813-2820 [PMID: 22719190 DOI: 10.3748/wjg.v18.i22.2813] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
18 Guyader D, Deugnier Y. Steatosis, iron and HFE genes. Journal of Hepatology 2008;48:514-5. [DOI: 10.1016/j.jhep.2007.12.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Heritage M, Jaskowski L, Bridle K, Campbell C, Briskey D, Britton L, Fletcher L, Vitetta L, Subramaniam VN, Crawford D. Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. World J Gastrointest Pathophysiol 2017; 8(2): 67-76 [PMID: 28573069 DOI: 10.4291/wjgp.v8.i2.67] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Deugnier Y, Brissot P, Loréal O. Iron and the liver: Update 2008. Journal of Hepatology 2008;48:S113-23. [DOI: 10.1016/j.jhep.2008.01.014] [Cited by in Crossref: 64] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
21 Fargion S, Valenti L, Fracanzani AL. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases. Dig Liver Dis. 2011;43:89-95. [PMID: 20739232 DOI: 10.1016/j.dld.2010.07.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
22 Adams PC, Speechley M, Barton JC, McLaren CE, McLaren GD, Eckfeldt JH. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology 2012;55:1722-6. [PMID: 22183642 DOI: 10.1002/hep.25538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
23 Frazer DM, Anderson GJ, Ramm GA, Subramaniam VN, Powell LW. How much iron is too much? Expert Review of Gastroenterology & Hepatology 2014;2:287-90. [DOI: 10.1586/17474124.2.3.287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Neri S, Pulvirenti D, Signorelli S, Ignaccolo L, Tsami A, Mauceri B, Misseri M, Interlandi D, Cutuli N, Castellino P. The HFE gene heterozygosis H63D: a cofactor for liver damage in patients with steatohepatitis? Epidemiological and clinical considerations. Intern Med J 2008;38:254-8. [PMID: 17916170 DOI: 10.1111/j.1445-5994.2007.01474.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
25 Lin H, Wei H, He N, Fu C, Cheng S, Shen J, Wang B, Yan X, Liu C, Yan F. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification. Eur Radiol 2018;28:3494-504. [PMID: 29470640 DOI: 10.1007/s00330-017-5263-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
26 Cheah DM, Deal YJ, Wright PF, Buck NE, Chow CW, Mercer JF, Allen KJ. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers. Biometals. 2007;20:751-757. [PMID: 17136311 DOI: 10.1007/s10534-006-9038-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
27 Aguilar-Martinez P, Grandchamp B, Cunat S, Cadet E, Blanc F, Nourrit M, Lassoued K, Schved JF, Rochette J. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica 2011;96:507-14. [PMID: 21228038 DOI: 10.3324/haematol.2010.029751] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
28 Hu F, Yang R, Huang Z, Wang M, Yuan F, Xia C, Wei Y, Song B. 3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study. Quant Imaging Med Surg. 2019;9:1014-1024. [PMID: 31367555 DOI: 10.21037/qims.2019.05.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Le Borgne F, Rigault C, Georges B, Demarquoy J. Hormonal and nutritional control of L-carnitine uptake in myoblastic C2C12 cells. Muscle Nerve 2008;38:912-5. [PMID: 18508344 DOI: 10.1002/mus.21008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Wood MJ, Powell LW, Dixon JL, Subramaniam VN, Ramm GA. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol 2013; 19(48): 9366-9376 [PMID: 24409064 DOI: 10.3748/wjg.v19.i48.9366] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Wachtel MS, Zhang Y, Kaye KE, Chiriva-internati M, Frezza EE. Increased Age, Male Gender, and Cirrhosis, but Not Steatosis or a Positive Viral Serology, Negatively Impact the Life Expectancy of Patients who Undergo Liver Biopsy. Dig Dis Sci 2007;52:2276-81. [DOI: 10.1007/s10620-006-9715-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 França M. Editorial for "Limits of Fat Quantification With Chemical Shift Encoded". J Magn Reson Imaging 2021;54:1175-6. [PMID: 33876877 DOI: 10.1002/jmri.27643] [Reference Citation Analysis]
33 Kovac U, Rozman D. Genetics of Non-alcoholic Fatty Liver Disease. In: John Wiley & Sons Ltd, editor. eLS. Chichester: John Wiley & Sons, Ltd; 2001. pp. 1-8. [DOI: 10.1002/9780470015902.a0025335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
34 Pelucchi S, Ravasi G, Arosio C, Mauri M, Piazza R, Mariani R, Piperno A. HIF1A: A Putative Modifier of Hemochromatosis. Int J Mol Sci 2021;22:1245. [PMID: 33513852 DOI: 10.3390/ijms22031245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kühn JP, Hernando D, Muñoz del Rio A, Evert M, Kannengiesser S, Völzke H, Mensel B, Puls R, Hosten N, Reeder SB. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265:133-42. [PMID: 22923718 DOI: 10.1148/radiol.12112520] [Cited by in Crossref: 121] [Cited by in F6Publishing: 119] [Article Influence: 12.1] [Reference Citation Analysis]
36 Nascimbeni F, Lugari S, Cassinerio E, Motta I, Cavicchioli A, Dalla Salda A, Bursi S, Donatiello S, Spina V, Cappellini MD, Andreone P, Carubbi F. Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease. Liver Int 2020;40:3061-70. [PMID: 32810900 DOI: 10.1111/liv.14640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
37 Peng Y, Ye J, Liu C, Jia H, Sun J, Ling J, Prince M, Li C, Luo X. Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat. Quant Imaging Med Surg 2021;11:2001-12. [PMID: 33936981 DOI: 10.21037/qims-20-902] [Reference Citation Analysis]
38 Österreicher; CH, Brenner DA. The genetics of nonalcoholic fatty liver disease. Annals of Hepatology 2007;6:83-8. [DOI: 10.1016/s1665-2681(19)31936-2] [Cited by in Crossref: 16] [Article Influence: 1.1] [Reference Citation Analysis]
39 Hickman IJ, Macdonald GA. Impact of diabetes on the severity of liver disease. Am J Med. 2007;120:829-834. [PMID: 17904449 DOI: 10.1016/j.amjmed.2007.03.025] [Cited by in Crossref: 97] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
40 Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59:859-871. [PMID: 23751754 DOI: 10.1016/j.jhep.2013.05.044] [Cited by in Crossref: 223] [Cited by in F6Publishing: 203] [Article Influence: 24.8] [Reference Citation Analysis]
41 Duarte TL, Caldas C, Santos AG, Silva-Gomes S, Santos-Gonçalves A, Martins MJ, Porto G, Lopes JM. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis. Redox Biol 2017;11:157-69. [PMID: 27936457 DOI: 10.1016/j.redox.2016.11.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
42 Chen H, Zeng WK, Shi GZ, Gao M, Wang MZ, Shen J. Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis. World J Gastroenterol 2020; 26(33): 4996-5007 [PMID: 32952345 DOI: 10.3748/wjg.v26.i33.4996] [Reference Citation Analysis]
43 Lee SS, Lee Y, Kim N, Kim SW, Byun JH, Park SH, Lee MG, Ha HK. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease. J Magn Reson Imaging. 2011;33:1390-1398. [PMID: 21591008 DOI: 10.1002/jmri.22583] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
44 Gan EK, Ayonrinde OT, Trinder D, Olynyk JK. Phenotypic Expression of Hereditary Hemochromatosis: What Have We Learned from the Population Studies? Curr Gastroenterol Rep 2010;12:7-12. [DOI: 10.1007/s11894-009-0078-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Fitzsimons EJ, Cullis JO, Thomas DW, Tsochatzis E, Griffiths WJH; British Society for Haematology. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). Br J Haematol 2018;181:293-303. [PMID: 29663319 DOI: 10.1111/bjh.15164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
46 Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol. 2006;23:149-160. [PMID: 17355088 DOI: 10.1053/j.semdp.2006.11.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 6.5] [Reference Citation Analysis]
47 Tan TCH, Crawford DHG, Jaskowski LA, Murphy TM, Heritage ML, Subramaniam VN, Clouston AD, Anderson GJ, Fletcher LM. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011;301:G865-76. [DOI: 10.1152/ajpgi.00150.2011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
48 Riva A, Trombini P, Mariani R, Salvioni A, Coletti S, Bonfadini S, Paolini V, Pozzi M, Facchetti R, Bovo G, Piperno A. Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J Gastroenterol 2008; 14(30): 4745-4752 [PMID: 18720534 DOI: 10.3748/wjg.14.4745] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
49 Clouston AD, Jonsson JR, Powell EE. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others. Clin Liver Dis 2007;11:173-89, x. [PMID: 17544978 DOI: 10.1016/j.cld.2007.02.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
50 Yu S, Kim S, Paek M, Goo E, Ji Y, Choe B. Correlation between Hepatic Fat Content Using 3-Echo 3-D Dixon Method and Intravoxel Incoherent Motion (IVIM) Perfusion MR Imaging. Appl Magn Reson 2013;44:791-801. [DOI: 10.1007/s00723-013-0443-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
51 Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl. 2006;12:523-534. [PMID: 16555318 DOI: 10.1002/lt.20738] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 6.5] [Reference Citation Analysis]
52 Piperno A. Molecular diagnosis of hemochromatosis. Expert Opin Med Diagn 2013;7:161-77. [PMID: 23530886 DOI: 10.1517/17530059.2013.763794] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
53 Crawford DHG, Ross DGF, Jaskowski LA, Burke LJ, Britton LJ, Musgrave N, Briskey D, Rishi G, Bridle KR, Subramaniam VN. Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways. Biochim Biophys Acta Mol Basis Dis 2021;1867:166142. [PMID: 33839281 DOI: 10.1016/j.bbadis.2021.166142] [Reference Citation Analysis]
54 Tonkin JN, Knight B, Curtis D, Abraham LJ, Yeoh GC. Bone marrow cells play only a very minor role in chronic liver regeneration induced by a choline-deficient, ethionine-supplemented diet. Stem Cell Research 2008;1:195-204. [DOI: 10.1016/j.scr.2008.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
55 Wood MJ, Powell LW, Dixon JL, Ramm GA. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus. Hepatology. 2012;56:904-911. [PMID: 22422567 DOI: 10.1002/hep.25720] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
56 Sánchez-Luna SA, Brown KE. Clinical burden of liver disease from hemochromatosis at an academic medical center. Hepatol Commun 2017;1:453-9. [PMID: 29404472 DOI: 10.1002/hep4.1048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Williams R. Global challenges in liver disease. Hepatology 2006;44:521-6. [DOI: 10.1002/hep.21347] [Cited by in Crossref: 492] [Cited by in F6Publishing: 475] [Article Influence: 30.8] [Reference Citation Analysis]
58 Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372-384. [PMID: 20494470 DOI: 10.1016/j.jhep.2010.04.008] [Cited by in Crossref: 637] [Cited by in F6Publishing: 605] [Article Influence: 53.1] [Reference Citation Analysis]
59 Weiss G. Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat Rev Gastroenterol Hepatol. 2010;7:50-58. [PMID: 19918260 DOI: 10.1038/nrgastro.2009.201] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
60 McPherson S, Jonsson JR, Cowin GJ, O’Rourke P, Clouston AD, Volp A, Horsfall L, Jothimani D, Fawcett J, Galloway GJ. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol. 2009;51:389-397. [PMID: 19505740 DOI: 10.1016/j.jhep.2009.04.012] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 9.5] [Reference Citation Analysis]
61 Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1221-1228. [PMID: 17689296 DOI: 10.1016/j.cgh.2007.05.020] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 20.9] [Reference Citation Analysis]
62 Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD;  American Association for the Study of Liver Diseases. Liver biopsy. Hepatology. 2009;49:1017-1044. [PMID: 19243014 DOI: 10.1002/hep.22742] [Cited by in Crossref: 1217] [Cited by in F6Publishing: 1042] [Article Influence: 93.6] [Reference Citation Analysis]
63 Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A. BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease. Diabetes Metab Syndr Obes 2020;13:1179-88. [PMID: 32368111 DOI: 10.2147/DMSO.S240757] [Reference Citation Analysis]
64 Sirlin CB, Reeder SB. Magnetic resonance imaging quantification of liver iron. Magn Reson Imaging Clin N Am. 2010;18:359-381, ix. [PMID: 21094445 DOI: 10.1016/j.mric.2010.08.014] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 9.7] [Reference Citation Analysis]
65 Hübscher SG. Role of liver biopsy in disorders of iron metabolism. Diagnostic Histopathology 2008;14:577-85. [DOI: 10.1016/j.mpdhp.2008.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
66 Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S. ASH and NASH. Dig Dis 2011;29:202-10. [PMID: 21734385 DOI: 10.1159/000323886] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
67 Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388:706-716. [PMID: 26975792 DOI: 10.1016/s0140-6736(15)01315-x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 57] [Article Influence: 23.7] [Reference Citation Analysis]
68 Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13-20. [PMID: 21920839 DOI: 10.1016/j.clinre.2011.08.001] [Cited by in Crossref: 135] [Cited by in F6Publishing: 123] [Article Influence: 12.3] [Reference Citation Analysis]
69 Barton JC, Mcguire BM, Acton RT. HFE Hemochromatosis and Hepatic Sarcoid. The American Journal of the Medical Sciences 2009;337:386-90. [DOI: 10.1097/maj.0b013e318191ed17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
70 AlKhater SA. Paediatric non-alcoholic fatty liver disease: an overview. Obes Rev 2015;16:393-405. [PMID: 25753407 DOI: 10.1111/obr.12271] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
71 Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27. [PMID: 19542391 DOI: 10.2214/ajr.09.2601] [Cited by in Crossref: 128] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
72 Mathurin P. [Alcohol and the liver]. Gastroenterol Clin Biol 2009;33:840-9. [PMID: 19729258 DOI: 10.1016/j.gcb.2009.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Gan EK, Trinder D, Ayonrinde OT, Olynyk JK. Genetics of hereditary hemochromatosis: a clinical perspective. Expert Review of Endocrinology & Metabolism 2014;4:225-39. [DOI: 10.1586/eem.09.9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
74 Dyson JK, Mcpherson S, Anstee QM. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol 2013;66:1033-45. [DOI: 10.1136/jclinpath-2013-201620] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 5.6] [Reference Citation Analysis]
75 Lin H, Fu C, Kannengiesser S, Cheng S, Shen J, Dong H, Yan F. Quantitative analysis of hepatic iron in patients suspected of coexisting iron overload and steatosis using multi-echo single-voxel magnetic resonance spectroscopy: Comparison with fat-saturated multi-echo gradient echo sequence. J Magn Reson Imaging. 2018;48:205-213. [PMID: 29513377 DOI: 10.1002/jmri.25967] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
76 de Lima VM, Oliveira CP, Alves VA, Chammas MC, Oliveira EP, Stefano JT, de Mello ES, Cerri GG, Carrilho FJ, Caldwell SH. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol. 2008;49:1055-1061. [PMID: 18929425 DOI: 10.1016/j.jhep.2008.07.024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
77 İdilman İS, Akata D, Özmen MN, Karçaaltıncaba M. Different forms of iron accumulation in the liver on MRI. Diagn Interv Radiol 2016;22:22-8. [PMID: 26712679 DOI: 10.5152/dir.2015.15094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
78 Yoon H, Shin HJ, Kim MJ, Lee MJ. Quantitative Imaging in Pediatric Hepatobiliary Disease. Korean J Radiol 2019;20:1342-57. [PMID: 31464113 DOI: 10.3348/kjr.2019.0002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
79 Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(36): 8112-8122 [PMID: 27688653 DOI: 10.3748/wjg.v22.i36.8112] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
80 Pelucchi S, Galimberti S, Greni F, Rametta R, Mariani R, Pelloni I, Girelli D, Busti F, Ravasi G, Valsecchi MG, Valenti L, Piperno A. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis. J Gastroenterol Hepatol 2016;31:1342-8. [PMID: 26868056 DOI: 10.1111/jgh.13315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
81 Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology. 2007;46:1071-1080. [PMID: 17828789 DOI: 10.1002/hep.21885] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 6.6] [Reference Citation Analysis]
82 Krafft AJ, Loeffler RB, Song R, Bian X, McCarville MB, Hankins JS, Hillenbrand CM. Does fat suppression via chemically selective saturation affect R2*-MRI for transfusional iron overload assessment? A clinical evaluation at 1.5T and 3T. Magn Reson Med 2016;76:591-601. [PMID: 26308155 DOI: 10.1002/mrm.25868] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
83 Wood MJ, Skoien R, Powell LW. The global burden of iron overload. Hepatol Int. 2009;3:434-444. [PMID: 19669241 DOI: 10.1007/s12072-009-9144-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
84 Zhao R, Hamilton G, Brittain JH, Reeder SB, Hernando D. Design and evaluation of quantitative MRI phantoms to mimic the simultaneous presence of fat, iron, and fibrosis in the liver. Magn Reson Med 2021;85:734-47. [PMID: 32783200 DOI: 10.1002/mrm.28452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Dongiovanni P, Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target. Journal of Hepatology 2011;55:920-32. [DOI: 10.1016/j.jhep.2011.05.008] [Cited by in Crossref: 183] [Cited by in F6Publishing: 172] [Article Influence: 16.6] [Reference Citation Analysis]
86 Ackerman Z, Pappo O, Link G, Glazer M, Grozovski M. Liver toxicity of thioacetamide is increased by hepatocellular iron overload. Biol Trace Elem Res 2015;163:169-76. [PMID: 25161090 DOI: 10.1007/s12011-014-0110-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
87 Padda RS, Gkouvatsos K, Guido M, Mui J, Vali H, Pantopoulos K. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice. Am J Physiol Gastrointest Liver Physiol 2015;308:G251-61. [PMID: 25501544 DOI: 10.1152/ajpgi.00137.2014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
88 Moyer TP, Highsmith WE, Smyrk TC, Gross JB Jr. Hereditary hemochromatosis: laboratory evaluation. Clin Chim Acta 2011;412:1485-92. [PMID: 21510925 DOI: 10.1016/j.cca.2011.04.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
89 Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 2007; 13(35): 4755-4760 [PMID: 17729397 DOI: 10.3748/wjg.v13.i35.4755] [Cited by in CrossRef: 108] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
90 Fagan KJ, Pretorius CJ, Horsfall LU, Irvine KM, Wilgen U, Choi K, Fletcher LM, Tate J, Melino M, Nusrat S, Miller GC, Clouston AD, Ballard E, O'Rourke P, Lampe G, Ungerer JP, Powell EE. ELF score ≥9.8 indicates advanced hepatic fibrosis and is influenced by age, steatosis and histological activity. Liver Int 2015;35:1673-81. [PMID: 25495373 DOI: 10.1111/liv.12760] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
91 O’Brien J, Powell LW. Non-alcoholic fatty liver disease: is iron relevant? Hepatol Int. 2012;6:332-341. [PMID: 22020821 DOI: 10.1007/s12072-011-9304-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
92 Kanwar P, Kowdley KV. Diagnosis and treatment of hereditary hemochromatosis: an update. Expert Rev Gastroenterol Hepatol. 2013;7:517-530. [PMID: 23985001 DOI: 10.1586/17474124.2013.816114] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
93 Pelucchi S, Mariani R, Trombini P, Coletti S, Pozzi M, Paolini V, Barisani D, Piperno A. Expression of hepcidin and other iron-related genes in type 3 hemochromatosis due to a novel mutation in transferrin receptor-2. Haematologica 2009;94:276-9. [PMID: 19144662 DOI: 10.3324/haematol.13576] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
94 Wood MJ, Gadd VL, Powell LW, Ramm GA, Clouston AD. Ductular reaction in hereditary hemochromatosis: The link between hepatocyte senescence and fibrosis progression: Hepatology, Vol. 00, No. X, 2013. Hepatology 2014;59:848-57. [DOI: 10.1002/hep.26706] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
95 Valenti L, Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage. Hepatology. 2006;44:857-864. [PMID: 17006922 DOI: 10.1002/hep.21329] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
96 França M, Alberich-bayarri Á, Martí-bonmatí L, Oliveira P, Costa FE, Porto G, Vizcaíno JR, Gonzalez JS, Ribeiro E, Oliveira J, Pessegueiro Miranda H. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI. Abdom Radiol 2017;42:1434-43. [DOI: 10.1007/s00261-017-1048-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
97 An P, Wang H, Wu Q, Guo X, Wu A, Zhang Z, Zhang D, Xu X, Mao Q, Shen X, Zhang L, Xiong Z, He L, Liu Y, Min J, Zhou D, Wang F. Elevated serum transaminase activities were associated with increased serum levels of iron regulatory hormone hepcidin and hyperferritinemia risk. Sci Rep 2015;5:13106. [PMID: 26290281 DOI: 10.1038/srep13106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
98 Radford-smith DE, Powell EE, Powell LW. Haemochromatosis: a clinical update for the practising physician: Haemochromatosis: an update. Intern Med J 2018;48:509-16. [DOI: 10.1111/imj.13784] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
99 Piperno A, Pelucchi S, Mariani R. Inherited iron overload disorders. Transl Gastroenterol Hepatol 2020;5:25. [PMID: 32258529 DOI: 10.21037/tgh.2019.11.15] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
100 Hayward KL, Johnson AL, Horsfall LU, Moser C, Valery PC, Powell EE. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterol 2021;8:e000572. [PMID: 33568418 DOI: 10.1136/bmjgast-2020-000572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Diehl AM, Choi SS. The Liver in Type 2 Diabetes Mellitus. In: Feinglos MN, Bethel MA, editors. Type 2 Diabetes Mellitus. Totowa: Humana Press; 2008. pp. 351-64. [DOI: 10.1007/978-1-60327-043-4_21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
102 Kishanifarahani Z, Ahadi M, Kazeminejad B, Mollasharifi T, Saber Afsharian M, Sadeghi A, Bidari F, Jamali E, Hasanzadeh N, Movafagh A, Dehghan A, Moradi A, Moradi A. Inter-observer Variability in Histomorphological Evaluation of Non-neoplastic Liver Biopsy Tissue and Impact of Clinical Information on Final Diagnosis in Shahid Beheshti University of Medical Sciences Affiliated Hospitals. Iran J Pathol 2019;14:243-7. [PMID: 31583002 DOI: 10.30699/ijp.2019.99566.1985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
103 Híndi M, Levy C, Couto CA, Bejarano P, Mendes F. Primary biliary cirrhosis is more severe in overweight patients. J Clin Gastroenterol. 2013;47:e28-e32. [PMID: 23059407 DOI: 10.1097/mcg.0b013e318261e659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
104 Petrak J, Myslivcova D, Man P, Cmejla R, Cmejlova J, Vyoral D, Elleder M, Vulpe CD. Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle. Am J Physiol Gastrointest Liver Physiol 2007;292:G1490-8. [PMID: 17307722 DOI: 10.1152/ajpgi.00455.2006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
105 Fracanzani AL, Piperno A, Valenti L, Fraquelli M, Coletti S, Maraschi A, Consonni D, Coviello E, Conte D, Fargion S. Hemochromatosis in Italy in the last 30 years: Role of genetic and acquired factors. Hepatology 2010;51:501-10. [DOI: 10.1002/hep.23333] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
106 Rossi E, Olynyk JK, Jeffrey GP. Clinical penetrance of C282Y homozygous HFE hemochromatosis. Expert Review of Hematology 2014;1:205-16. [DOI: 10.1586/17474086.1.2.205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
107 Wagner J, Fillebeen C, Haliotis T, Charlebois E, Katsarou A, Mui J, Vali H, Pantopoulos K. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet. PLoS One 2019;14:e0221455. [PMID: 31442254 DOI: 10.1371/journal.pone.0221455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
108 Zhao F, Chen Y, Zhang H, Li C, Long L. Multi-echo Dixon and breath-hold T2-corrected multi-echo single-voxel MRS for quantifying hepatic iron overload in rabbits. Acta Radiol 2021;:2841851211063007. [PMID: 34904894 DOI: 10.1177/02841851211063007] [Reference Citation Analysis]